Lantheus Holdings (LNTH) Research & Development (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Research & Development came in at $39.4 million in Q1 2026, down 7.35% year-on-year from $42.5 million in Q1 2025, and up 132.5% on a QoQ basis from -$121.2 million in Q4 2025.

Lantheus Holdings (LNTH) Research & Development (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Research & Development data on file, last reported at $39.4 million in Q1 2026.

  • On a quarterly basis, Research & Development fell 7.35% year-over-year to $39.4 million in Q1 2026; TTM through Mar 2026 was $7.3 million, a 97.15% decrease from a year earlier, with the FY2025 full-year figure at $11.2 million, down 93.34% from the prior year.
  • Research & Development for Q1 2026 stood at $39.4 million, up from -$121.2 million in the prior quarter.
  • Over the last five years, Research & Development for LNTH reached as high as $220.5 million in Q4 2022 and fell as low as -$121.2 million in Q4 2025.
  • Historically, Research & Development has averaged $43.0 million across 5 years, with a median of $37.4 million in 2023.
  • Across the five-year window, Research & Development soared 5568.51% in 2022 and plunged 191.73% in 2025, its largest moves.
  • Year by year, Research & Development stood at $220.5 million in 2022, then sank by 63.34% to $80.9 million in 2023, then soared by 63.38% to $132.1 million in 2024, then plunged by 191.73% to -$121.2 million in 2025, then soared by 132.5% to $39.4 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $39.4 million in Q1 2026, -$121.2 million in Q4 2025, and $48.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 138.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 97.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 39.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.38 Mn
Dec 31, 2025 -121.17 Mn
Sep 30, 2025 48.03 Mn
Jun 30, 2025 41.04 Mn
Mar 31, 2025 42.50 Mn
Dec 31, 2024 132.10 Mn
Sep 30, 2024 36.00 Mn
Jun 30, 2024 45.04 Mn
Mar 31, 2024 28.00 Mn
Dec 31, 2023 80.85 Mn
Sep 30, 2023 37.40 Mn
Jun 30, 2023 15.90 Mn
Mar 31, 2023 32.62 Mn
Dec 31, 2022 220.55 Mn
Sep 30, 2022 25.41 Mn
Jun 30, 2022 14.74 Mn
Mar 31, 2022 12.20 Mn
Dec 31, 2021 -4.03 Mn
Sep 30, 2021 11.25 Mn
Jun 30, 2021 12.06 Mn